RMD Filing
4Filing Date: Apr 3, 2026
RESMED INC (RMD) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0000943819-26-000020open_in_new
Total Value$224.3K
Trades1
Insiders1
Transaction Details
Sandercock Brett
Chief Financial Officer·Direct
Sell · Dispose
ResMed Common Stock
Shares-1.00K
Price$224.31
Total Value$224.3K
Shares Owned After83.50K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸
The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
Post-Transaction Holdings
Sandercock Brett
| Security | Shares | Change |
|---|---|---|
| ResMed Common Stock | 83.50K | -1.00K (-1.18%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-04-01
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: RESMED INC (RMD)
CIK: 0000943819
--- Reporting Owner ---
Name: Sandercock Brett
CIK: 0001346064
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: ResMed Common Stock
Date: 2026-04-01 | Code: S (Open market sale)
Shares: -1,000 | Price: $224.31
Total Value: $224,310.00
Shares Owned After: 83,495 | Ownership: D (Direct)
Footnotes:
[F1] The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
--- Footnotes (Complete Index) ---
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
--- Signature ---
/s/ /s/ Brett Sandercock, Chief Financial Officer (2026-04-02)